We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Method of Optimizing CHO Cells for Large Scale Bioprocess
Product News

New Method of Optimizing CHO Cells for Large Scale Bioprocess

New Method of Optimizing CHO Cells for Large Scale Bioprocess
Product News

New Method of Optimizing CHO Cells for Large Scale Bioprocess


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New Method of Optimizing CHO Cells for Large Scale Bioprocess"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Invitrogen announces PD-Direct™, its fully integrated service for customized bioprocess development, is hosting a Technology Tutorial on developing novel types of CHO cells at 12.35pm on Tuesday, March 4th in the Main Hall of the European Cell Line Development and Engineering Conference being held at the Corinthia Panorama in Prague.

The presentation, entitled "Engineering of Novel Platform Cell Lines with Phenotypic Traits Advantageous for Bioproduction", will help scientists understand how Invitrogen is using its PD-Direct™ Revolution™ technology.

Dr Jonathan Dempsey, Process Science Fellow at Invitrogen PD-Direct™, a scientist with many years’ experience in developing cell culture manufacturing processes and cell lines, will discuss how Revolution™ enables optimization of CHO cells by accelerating gene evolution. This combined with screening and selection techniques can produce cells resistant to high osmolality and therefore better adapted to large scale bioprocess.

Dr Jonathan Dempsey, Process Science Fellow at Invitrogen PD-Directa said: "In recent years, cutting development time to produce profitable biopharmaceuticals is becoming critical for many pharma and biotechs companies. I’m looking forward to presenting the data and to discussing the benefits of using Revolution™ for generating cell lines with improved phenotypic traits for bioprocessing at our Technology Tutorial at European Cell Line Development and Engineering in Prague, because optimizing the host cell line promises to be a powerful new approach to improving large scale bioprocessing.”

Advertisement